Yan Lin
Fujian Medical University(CN)Guangxi Medical University(CN)Eli Lilly (United States)(US)Second Military Medical University(CN)Guangxi Science and Technology Department(CN)Changhai Hospital(CN)Tumor Hospital of Guangxi Medical University(CN)Institute of Hydroecology(CN)Southern Medical University(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Hepatocellular Carcinoma Treatment and Prognosis, Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis
Most-Cited Works
- → Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro(2012)464 cited
- → Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma(2015)382 cited
- → Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab(2014)309 cited
- → Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma(2019)246 cited
- → An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection(2012)208 cited
- → Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer